Global Substance Abuse Treatment

Substance Abuse Treatment Comprehensive Study by Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Drug Abuse Treatment, Other Treatment), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), End User (Hospitals, Homecare, Specialty Clinics, Others) Players and Region - Global Market Outlook to 2030

Substance Abuse Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Substance Abuse Treatment market is expected to grow in the future due to the rise in the drug awareness campaigns and associated prevention programs and adoption of newer formulations and novel dosage forms. Substance abuse is the repeated harmful use of any substance, including drugs and alcohol. The substances may be legal, prescription drugs or banned substances as well some that aren’t even classified as drugs. Technological advancement in the diagnostics industry is boosting the growth of the market.

Highlights from Substance Abuse Treatment Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The key Players profiled in the report are Allergan plc (United States), Sanofi S.A (France), GSK (United Kingdom), Pfizer Inc. (United States), Alkermes (Ireland), Mylan N.V. (United States), Cipla Limited (India), Purdue Pharma L.P. (United States), Reckitt Benckiser Group plc (United Kingdom) and Teva Pharmaceutical (Israel). Additionally, other players that are part of this comprehensive study are Wellspring Addiction Treatment and Research Center (United States), Foundations Recovery Network (Tennessee) and The Jed Foundation (United States).

Geographic Breakdown and Segment Analysis
The Global Substance Abuse Treatment market presents a comprehensive analysis of the Substance Abuse Treatment market by product type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Drug Abuse Treatment and Other Treatment), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Substance Abuse Treatment industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Substance Abuse Treatment market

Analyst at AMA have segmented the market study of Global Substance Abuse Treatment market by Type, Application and Region.

Influencing Trend:
Technological Advancement in the Diagnostics Industry

Market Growth Drivers:
Increasing Number of Drug Awareness Campaigns and Prevention Programs and High Number of Addicted Population

Challenges:
Poor Treatment Compliance in Some Countries

Restraints:
Reluctance of Individuals for Accessing Treatment and Discontinuation of the Behavioral Therapies

Opportunities:
High Usage of Tobacco across the Developing and Developed Nations, Growing Healthcare Infrastructure in the Developing Economies and Availability of Cost Effective Treatment Option

Market Developments Activities:
In December 2023, Shatterproof Announced a new partnership with the NFL to raise awareness about addiction and promote recovery resources. The Shatterproof-NFL partnership marks a crucial step forward in the fight against addiction. By harnessing the reach and influence of the NFL, Shatterproof can significantly amplify its efforts to raise awareness, break down stigma, and ensure that everyone affected by addiction has access to the resources and support they need to heal and thrive.
In August 2023, Recovery.org Launched a new online platform connecting individuals with addiction treatment resources and support groups. The new online platform represents a significant advancement in the accessibility and visibility of addiction treatment and recovery resources. Its potential to empower individuals, reduce stigma, and support the journey of recovery is substantial. As the platform evolves and addresses potential challenges, it can make a lasting impact on the lives of countless individuals affected by addiction.



The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Key Target Audience
Pharmaceutical Companies, Pharmacy Chains/Drug Stores, Drug Suppliers/Traders, Drug Exporters/Importers, Investors, Regulatory and Government Bodies, Upstream Vendors, Downstream Vendors and Others

Report Objectives / Segmentation Covered

By Type
  • Alcohol Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Drug Abuse Treatment
  • Other Treatment
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

By End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Drug Awareness Campaigns and Prevention Programs
      • 3.2.2. High Number of Addicted Population
    • 3.3. Market Challenges
      • 3.3.1. Poor Treatment Compliance in Some Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in the Diagnostics Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Substance Abuse Treatment, by Type, Distribution Channel, End User and Region (value and volume ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Substance Abuse Treatment (Value)
      • 5.2.1. Global Substance Abuse Treatment by: Type (Value)
        • 5.2.1.1. Alcohol Addiction Treatment
        • 5.2.1.2. Tobacco/Nicotine Addiction Treatment
        • 5.2.1.3. Drug Abuse Treatment
        • 5.2.1.4. Other Treatment
      • 5.2.2. Global Substance Abuse Treatment by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Other Distribution Channels
      • 5.2.3. Global Substance Abuse Treatment by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Homecare
        • 5.2.3.3. Specialty Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Substance Abuse Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Substance Abuse Treatment (Volume)
      • 5.3.1. Global Substance Abuse Treatment by: Type (Volume)
        • 5.3.1.1. Alcohol Addiction Treatment
        • 5.3.1.2. Tobacco/Nicotine Addiction Treatment
        • 5.3.1.3. Drug Abuse Treatment
        • 5.3.1.4. Other Treatment
      • 5.3.2. Global Substance Abuse Treatment by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital Pharmacies
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Other Distribution Channels
      • 5.3.3. Global Substance Abuse Treatment by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Homecare
        • 5.3.3.3. Specialty Clinics
        • 5.3.3.4. Others
      • 5.3.4. Global Substance Abuse Treatment Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
  • 6. Substance Abuse Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan plc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi S.A (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GSK (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Alkermes (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mylan N.V. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cipla Limited (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Purdue Pharma L.P. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Reckitt Benckiser Group plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Substance Abuse Treatment Sale, by Type, Distribution Channel, End User and Region (value and volume ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Substance Abuse Treatment (Value)
      • 7.2.1. Global Substance Abuse Treatment by: Type (Value)
        • 7.2.1.1. Alcohol Addiction Treatment
        • 7.2.1.2. Tobacco/Nicotine Addiction Treatment
        • 7.2.1.3. Drug Abuse Treatment
        • 7.2.1.4. Other Treatment
      • 7.2.2. Global Substance Abuse Treatment by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Other Distribution Channels
      • 7.2.3. Global Substance Abuse Treatment by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Homecare
        • 7.2.3.3. Specialty Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Substance Abuse Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Substance Abuse Treatment (Volume)
      • 7.3.1. Global Substance Abuse Treatment by: Type (Volume)
        • 7.3.1.1. Alcohol Addiction Treatment
        • 7.3.1.2. Tobacco/Nicotine Addiction Treatment
        • 7.3.1.3. Drug Abuse Treatment
        • 7.3.1.4. Other Treatment
      • 7.3.2. Global Substance Abuse Treatment by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital Pharmacies
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Other Distribution Channels
      • 7.3.3. Global Substance Abuse Treatment by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Homecare
        • 7.3.3.3. Specialty Clinics
        • 7.3.3.4. Others
      • 7.3.4. Global Substance Abuse Treatment Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Substance Abuse Treatment: by Type(USD Million)
  • Table 2. Substance Abuse Treatment Alcohol Addiction Treatment , by Region USD Million (2018-2023)
  • Table 3. Substance Abuse Treatment Tobacco/Nicotine Addiction Treatment , by Region USD Million (2018-2023)
  • Table 4. Substance Abuse Treatment Drug Abuse Treatment , by Region USD Million (2018-2023)
  • Table 5. Substance Abuse Treatment Other Treatment , by Region USD Million (2018-2023)
  • Table 6. Substance Abuse Treatment: by Distribution Channel(USD Million)
  • Table 7. Substance Abuse Treatment Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 8. Substance Abuse Treatment Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 9. Substance Abuse Treatment Other Distribution Channels , by Region USD Million (2018-2023)
  • Table 10. Substance Abuse Treatment: by End User(USD Million)
  • Table 11. Substance Abuse Treatment Hospitals , by Region USD Million (2018-2023)
  • Table 12. Substance Abuse Treatment Homecare , by Region USD Million (2018-2023)
  • Table 13. Substance Abuse Treatment Specialty Clinics , by Region USD Million (2018-2023)
  • Table 14. Substance Abuse Treatment Others , by Region USD Million (2018-2023)
  • Table 15. South America Substance Abuse Treatment, by Country USD Million (2018-2023)
  • Table 16. South America Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 17. South America Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 18. South America Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 19. Brazil Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 20. Brazil Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 21. Brazil Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 22. Argentina Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 23. Argentina Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 24. Argentina Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 25. Rest of South America Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 27. Rest of South America Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 28. Asia Pacific Substance Abuse Treatment, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 31. Asia Pacific Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 32. China Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 33. China Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 34. China Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 35. Japan Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 36. Japan Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 37. Japan Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 38. India Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 39. India Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 40. India Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 41. South Korea Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 42. South Korea Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 43. South Korea Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 44. Taiwan Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 45. Taiwan Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 46. Taiwan Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 47. Australia Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 48. Australia Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 49. Australia Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 53. Europe Substance Abuse Treatment, by Country USD Million (2018-2023)
  • Table 54. Europe Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 55. Europe Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 56. Europe Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 57. Germany Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 58. Germany Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 59. Germany Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 60. France Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 61. France Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 62. France Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 63. Italy Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 64. Italy Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 65. Italy Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 66. United Kingdom Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 68. United Kingdom Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 69. Netherlands Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 70. Netherlands Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 71. Netherlands Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 72. Rest of Europe Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 74. Rest of Europe Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 75. MEA Substance Abuse Treatment, by Country USD Million (2018-2023)
  • Table 76. MEA Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 77. MEA Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 78. MEA Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 79. Middle East Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 80. Middle East Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 81. Middle East Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 82. Africa Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 83. Africa Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 84. Africa Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 85. North America Substance Abuse Treatment, by Country USD Million (2018-2023)
  • Table 86. North America Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 87. North America Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 88. North America Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 89. United States Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 90. United States Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 91. United States Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 92. Canada Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 93. Canada Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 94. Canada Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 95. Mexico Substance Abuse Treatment, by Type USD Million (2018-2023)
  • Table 96. Mexico Substance Abuse Treatment, by Distribution Channel USD Million (2018-2023)
  • Table 97. Mexico Substance Abuse Treatment, by End User USD Million (2018-2023)
  • Table 98. Substance Abuse Treatment Sales: by Type(K Units)
  • Table 99. Substance Abuse Treatment Sales Alcohol Addiction Treatment , by Region K Units (2018-2023)
  • Table 100. Substance Abuse Treatment Sales Tobacco/Nicotine Addiction Treatment , by Region K Units (2018-2023)
  • Table 101. Substance Abuse Treatment Sales Drug Abuse Treatment , by Region K Units (2018-2023)
  • Table 102. Substance Abuse Treatment Sales Other Treatment , by Region K Units (2018-2023)
  • Table 103. Substance Abuse Treatment Sales: by Distribution Channel(K Units)
  • Table 104. Substance Abuse Treatment Sales Hospital Pharmacies , by Region K Units (2018-2023)
  • Table 105. Substance Abuse Treatment Sales Retail Pharmacies , by Region K Units (2018-2023)
  • Table 106. Substance Abuse Treatment Sales Other Distribution Channels , by Region K Units (2018-2023)
  • Table 107. Substance Abuse Treatment Sales: by End User(K Units)
  • Table 108. Substance Abuse Treatment Sales Hospitals , by Region K Units (2018-2023)
  • Table 109. Substance Abuse Treatment Sales Homecare , by Region K Units (2018-2023)
  • Table 110. Substance Abuse Treatment Sales Specialty Clinics , by Region K Units (2018-2023)
  • Table 111. Substance Abuse Treatment Sales Others , by Region K Units (2018-2023)
  • Table 112. South America Substance Abuse Treatment Sales, by Country K Units (2018-2023)
  • Table 113. South America Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 114. South America Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 115. South America Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 116. Brazil Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 117. Brazil Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 118. Brazil Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 119. Argentina Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 120. Argentina Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 121. Argentina Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 122. Rest of South America Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 123. Rest of South America Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 124. Rest of South America Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 125. Asia Pacific Substance Abuse Treatment Sales, by Country K Units (2018-2023)
  • Table 126. Asia Pacific Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 127. Asia Pacific Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 128. Asia Pacific Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 129. China Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 130. China Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 131. China Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 132. Japan Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 133. Japan Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 134. Japan Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 135. India Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 136. India Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 137. India Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 138. South Korea Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 139. South Korea Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 140. South Korea Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 141. Taiwan Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 142. Taiwan Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 143. Taiwan Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 144. Australia Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 145. Australia Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 146. Australia Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 147. Rest of Asia-Pacific Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 148. Rest of Asia-Pacific Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 149. Rest of Asia-Pacific Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 150. Europe Substance Abuse Treatment Sales, by Country K Units (2018-2023)
  • Table 151. Europe Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 152. Europe Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 153. Europe Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 154. Germany Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 155. Germany Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 156. Germany Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 157. France Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 158. France Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 159. France Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 160. Italy Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 161. Italy Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 162. Italy Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 163. United Kingdom Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 164. United Kingdom Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 165. United Kingdom Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 166. Netherlands Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 167. Netherlands Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 168. Netherlands Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 169. Rest of Europe Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 170. Rest of Europe Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 171. Rest of Europe Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 172. MEA Substance Abuse Treatment Sales, by Country K Units (2018-2023)
  • Table 173. MEA Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 174. MEA Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 175. MEA Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 176. Middle East Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 177. Middle East Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 178. Middle East Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 179. Africa Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 180. Africa Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 181. Africa Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 182. North America Substance Abuse Treatment Sales, by Country K Units (2018-2023)
  • Table 183. North America Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 184. North America Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 185. North America Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 186. United States Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 187. United States Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 188. United States Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 189. Canada Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 190. Canada Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 191. Canada Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 192. Mexico Substance Abuse Treatment Sales, by Type K Units (2018-2023)
  • Table 193. Mexico Substance Abuse Treatment Sales, by Distribution Channel K Units (2018-2023)
  • Table 194. Mexico Substance Abuse Treatment Sales, by End User K Units (2018-2023)
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Substance Abuse Treatment: by Type(USD Million)
  • Table 206. Substance Abuse Treatment Alcohol Addiction Treatment , by Region USD Million (2025-2030)
  • Table 207. Substance Abuse Treatment Tobacco/Nicotine Addiction Treatment , by Region USD Million (2025-2030)
  • Table 208. Substance Abuse Treatment Drug Abuse Treatment , by Region USD Million (2025-2030)
  • Table 209. Substance Abuse Treatment Other Treatment , by Region USD Million (2025-2030)
  • Table 210. Substance Abuse Treatment: by Distribution Channel(USD Million)
  • Table 211. Substance Abuse Treatment Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 212. Substance Abuse Treatment Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 213. Substance Abuse Treatment Other Distribution Channels , by Region USD Million (2025-2030)
  • Table 214. Substance Abuse Treatment: by End User(USD Million)
  • Table 215. Substance Abuse Treatment Hospitals , by Region USD Million (2025-2030)
  • Table 216. Substance Abuse Treatment Homecare , by Region USD Million (2025-2030)
  • Table 217. Substance Abuse Treatment Specialty Clinics , by Region USD Million (2025-2030)
  • Table 218. Substance Abuse Treatment Others , by Region USD Million (2025-2030)
  • Table 219. South America Substance Abuse Treatment, by Country USD Million (2025-2030)
  • Table 220. South America Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 221. South America Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 222. South America Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 223. Brazil Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 224. Brazil Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 225. Brazil Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 226. Argentina Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 227. Argentina Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 228. Argentina Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 229. Rest of South America Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 230. Rest of South America Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 231. Rest of South America Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 232. Asia Pacific Substance Abuse Treatment, by Country USD Million (2025-2030)
  • Table 233. Asia Pacific Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 234. Asia Pacific Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 235. Asia Pacific Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 236. China Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 237. China Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 238. China Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 239. Japan Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 240. Japan Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 241. Japan Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 242. India Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 243. India Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 244. India Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 245. South Korea Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 246. South Korea Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 247. South Korea Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 248. Taiwan Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 249. Taiwan Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 250. Taiwan Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 251. Australia Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 252. Australia Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 253. Australia Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 257. Europe Substance Abuse Treatment, by Country USD Million (2025-2030)
  • Table 258. Europe Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 259. Europe Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 260. Europe Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 261. Germany Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 262. Germany Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 263. Germany Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 264. France Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 265. France Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 266. France Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 267. Italy Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 268. Italy Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 269. Italy Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 270. United Kingdom Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 271. United Kingdom Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 272. United Kingdom Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 273. Netherlands Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 274. Netherlands Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 275. Netherlands Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 276. Rest of Europe Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 277. Rest of Europe Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 278. Rest of Europe Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 279. MEA Substance Abuse Treatment, by Country USD Million (2025-2030)
  • Table 280. MEA Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 281. MEA Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 282. MEA Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 283. Middle East Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 284. Middle East Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 285. Middle East Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 286. Africa Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 287. Africa Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 288. Africa Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 289. North America Substance Abuse Treatment, by Country USD Million (2025-2030)
  • Table 290. North America Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 291. North America Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 292. North America Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 293. United States Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 294. United States Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 295. United States Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 296. Canada Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 297. Canada Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 298. Canada Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 299. Mexico Substance Abuse Treatment, by Type USD Million (2025-2030)
  • Table 300. Mexico Substance Abuse Treatment, by Distribution Channel USD Million (2025-2030)
  • Table 301. Mexico Substance Abuse Treatment, by End User USD Million (2025-2030)
  • Table 302. Substance Abuse Treatment Sales: by Type(K Units)
  • Table 303. Substance Abuse Treatment Sales Alcohol Addiction Treatment , by Region K Units (2025-2030)
  • Table 304. Substance Abuse Treatment Sales Tobacco/Nicotine Addiction Treatment , by Region K Units (2025-2030)
  • Table 305. Substance Abuse Treatment Sales Drug Abuse Treatment , by Region K Units (2025-2030)
  • Table 306. Substance Abuse Treatment Sales Other Treatment , by Region K Units (2025-2030)
  • Table 307. Substance Abuse Treatment Sales: by Distribution Channel(K Units)
  • Table 308. Substance Abuse Treatment Sales Hospital Pharmacies , by Region K Units (2025-2030)
  • Table 309. Substance Abuse Treatment Sales Retail Pharmacies , by Region K Units (2025-2030)
  • Table 310. Substance Abuse Treatment Sales Other Distribution Channels , by Region K Units (2025-2030)
  • Table 311. Substance Abuse Treatment Sales: by End User(K Units)
  • Table 312. Substance Abuse Treatment Sales Hospitals , by Region K Units (2025-2030)
  • Table 313. Substance Abuse Treatment Sales Homecare , by Region K Units (2025-2030)
  • Table 314. Substance Abuse Treatment Sales Specialty Clinics , by Region K Units (2025-2030)
  • Table 315. Substance Abuse Treatment Sales Others , by Region K Units (2025-2030)
  • Table 316. South America Substance Abuse Treatment Sales, by Country K Units (2025-2030)
  • Table 317. South America Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 318. South America Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 319. South America Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 320. Brazil Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 321. Brazil Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 322. Brazil Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 323. Argentina Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 324. Argentina Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 325. Argentina Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 326. Rest of South America Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 327. Rest of South America Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 328. Rest of South America Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 329. Asia Pacific Substance Abuse Treatment Sales, by Country K Units (2025-2030)
  • Table 330. Asia Pacific Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 331. Asia Pacific Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 332. Asia Pacific Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 333. China Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 334. China Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 335. China Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 336. Japan Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 337. Japan Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 338. Japan Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 339. India Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 340. India Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 341. India Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 342. South Korea Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 343. South Korea Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 344. South Korea Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 345. Taiwan Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 346. Taiwan Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 347. Taiwan Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 348. Australia Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 349. Australia Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 350. Australia Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 351. Rest of Asia-Pacific Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 352. Rest of Asia-Pacific Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 353. Rest of Asia-Pacific Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 354. Europe Substance Abuse Treatment Sales, by Country K Units (2025-2030)
  • Table 355. Europe Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 356. Europe Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 357. Europe Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 358. Germany Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 359. Germany Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 360. Germany Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 361. France Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 362. France Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 363. France Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 364. Italy Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 365. Italy Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 366. Italy Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 367. United Kingdom Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 368. United Kingdom Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 369. United Kingdom Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 370. Netherlands Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 371. Netherlands Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 372. Netherlands Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 373. Rest of Europe Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 374. Rest of Europe Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 375. Rest of Europe Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 376. MEA Substance Abuse Treatment Sales, by Country K Units (2025-2030)
  • Table 377. MEA Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 378. MEA Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 379. MEA Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 380. Middle East Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 381. Middle East Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 382. Middle East Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 383. Africa Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 384. Africa Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 385. Africa Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 386. North America Substance Abuse Treatment Sales, by Country K Units (2025-2030)
  • Table 387. North America Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 388. North America Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 389. North America Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 390. United States Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 391. United States Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 392. United States Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 393. Canada Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 394. Canada Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 395. Canada Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 396. Mexico Substance Abuse Treatment Sales, by Type K Units (2025-2030)
  • Table 397. Mexico Substance Abuse Treatment Sales, by Distribution Channel K Units (2025-2030)
  • Table 398. Mexico Substance Abuse Treatment Sales, by End User K Units (2025-2030)
  • Table 399. Research Programs/Design for This Report
  • Table 400. Key Data Information from Secondary Sources
  • Table 401. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Substance Abuse Treatment: by Type USD Million (2018-2023)
  • Figure 5. Global Substance Abuse Treatment: by Distribution Channel USD Million (2018-2023)
  • Figure 6. Global Substance Abuse Treatment: by End User USD Million (2018-2023)
  • Figure 7. South America Substance Abuse Treatment Share (%), by Country
  • Figure 8. Asia Pacific Substance Abuse Treatment Share (%), by Country
  • Figure 9. Europe Substance Abuse Treatment Share (%), by Country
  • Figure 10. MEA Substance Abuse Treatment Share (%), by Country
  • Figure 11. North America Substance Abuse Treatment Share (%), by Country
  • Figure 12. Global Substance Abuse Treatment: by Type K Units (2018-2023)
  • Figure 13. Global Substance Abuse Treatment: by Distribution Channel K Units (2018-2023)
  • Figure 14. Global Substance Abuse Treatment: by End User K Units (2018-2023)
  • Figure 15. South America Substance Abuse Treatment Share (%), by Country
  • Figure 16. Asia Pacific Substance Abuse Treatment Share (%), by Country
  • Figure 17. Europe Substance Abuse Treatment Share (%), by Country
  • Figure 18. MEA Substance Abuse Treatment Share (%), by Country
  • Figure 19. North America Substance Abuse Treatment Share (%), by Country
  • Figure 20. Global Substance Abuse Treatment share by Players 2023 (%)
  • Figure 21. Global Substance Abuse Treatment share by Players (Top 3) 2023(%)
  • Figure 22. Global Substance Abuse Treatment share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Allergan plc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Allergan plc (United States) Revenue: by Geography 2023
  • Figure 26. Sanofi S.A (France) Revenue, Net Income and Gross profit
  • Figure 27. Sanofi S.A (France) Revenue: by Geography 2023
  • Figure 28. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. GSK (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Pfizer Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Alkermes (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. Alkermes (Ireland) Revenue: by Geography 2023
  • Figure 34. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Mylan N.V. (United States) Revenue: by Geography 2023
  • Figure 36. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 37. Cipla Limited (India) Revenue: by Geography 2023
  • Figure 38. Purdue Pharma L.P. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Purdue Pharma L.P. (United States) Revenue: by Geography 2023
  • Figure 40. Reckitt Benckiser Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 41. Reckitt Benckiser Group plc (United Kingdom) Revenue: by Geography 2023
  • Figure 42. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 43. Teva Pharmaceutical (Israel) Revenue: by Geography 2023
  • Figure 44. Global Substance Abuse Treatment: by Type USD Million (2025-2030)
  • Figure 45. Global Substance Abuse Treatment: by Distribution Channel USD Million (2025-2030)
  • Figure 46. Global Substance Abuse Treatment: by End User USD Million (2025-2030)
  • Figure 47. South America Substance Abuse Treatment Share (%), by Country
  • Figure 48. Asia Pacific Substance Abuse Treatment Share (%), by Country
  • Figure 49. Europe Substance Abuse Treatment Share (%), by Country
  • Figure 50. MEA Substance Abuse Treatment Share (%), by Country
  • Figure 51. North America Substance Abuse Treatment Share (%), by Country
  • Figure 52. Global Substance Abuse Treatment: by Type K Units (2025-2030)
  • Figure 53. Global Substance Abuse Treatment: by Distribution Channel K Units (2025-2030)
  • Figure 54. Global Substance Abuse Treatment: by End User K Units (2025-2030)
  • Figure 55. South America Substance Abuse Treatment Share (%), by Country
  • Figure 56. Asia Pacific Substance Abuse Treatment Share (%), by Country
  • Figure 57. Europe Substance Abuse Treatment Share (%), by Country
  • Figure 58. MEA Substance Abuse Treatment Share (%), by Country
  • Figure 59. North America Substance Abuse Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergan plc (United States)
  • Sanofi S.A (France)
  • GSK (United Kingdom)
  • Pfizer Inc. (United States)
  • Alkermes (Ireland)
  • Mylan N.V. (United States)
  • Cipla Limited (India)
  • Purdue Pharma L.P. (United States)
  • Reckitt Benckiser Group plc (United Kingdom)
  • Teva Pharmaceutical (Israel)
Additional players considered in the study are as follows:
Wellspring Addiction Treatment and Research Center (United States) , Foundations Recovery Network (Tennessee) , The Jed Foundation (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 249 Pages 53 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Substance Abuse Treatment Quantitative research analysis
Global Substance Abuse Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Poor Treatment Compliance in Some Countries

Know More About Global Substance Abuse Treatment Report?

Have a Query? Click Here

Other Related Reports

Hemophilia Treatment Comprehensive Study by Type (Replacement therapy, ITI therapy, Gene therapy), Disease Type (Hemophilia A, Hemophilia B, Hemophilia C), Treatment (Recombinant Coagulation Factor, ...
$ 3650
Gastrointestinal Cancer Drugs Comprehensive Study by Application (Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers), Drug Type (Ramucirumab, Docetaxel, Doxorubici...
$ 3750
Hormone Refractory Prostate Cancer Comprehensive Study by Treatment (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Surgery), End-users (Hospitals, Ambulatory Surgical Centers, Spe...
$ 3650
Metastatic Uveal Melanoma Thereapeutics Comprehensive Study by Type (Sunitinib Malate, Vincristine Sulfate Liposomal, LY-2801653, Sotrastaurin Acetate, Others), Application (Hospital, Clinic, Others)...
$ 3750
Brachytherapy Comprehensive Study by Type (High Dose Rate (HDR) Brachytherapy , Low Dose (LDR) Brachytherapy), Application (Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Cancers), End U...
$ 3450
Q Fever Comprehensive Study by Type (Acute Q Fever, Chronic Q Fever), Treatment (Medicines (Doxycycline), Vaccination), End-users (Hospitals & Clinics, Diagnostic Centers, Surgical Centers), Diagnosi...
$ 3450